We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Final Guidance Advises on ANDA Labeling Updates for Reference Drug Changes
FDA Final Guidance Advises on ANDA Labeling Updates for Reference Drug Changes
Two significant changes in the FDA’s final guidance on updating ANDA labeling are details on how to obtain information on changes to reference listed drug (RLD) labeling and how to submit revised ANDA labeling.
